Proteo® Super early detection of cancer
PROTEO
With early detection, the 5-year survival rate is over 95%!
do you know? The time has come when most cancers that are detected early can be completely cured.
If no recurrence is seen for 5 years after the end of treatment, it is generally expressed as "completely cured", but if you look at the data*1 published by the National Cancer Center Association,
<In the case of those who have discovered cancer at stage I and underwent surgery>
The 5-year relative survival rate is announced to be 95.4% for all cancers, and 100% for stomach cancer, rectal cancer, and breast cancer.
However, if the diagnosis is delayed and progresses to stage IV, the 5-year relative survival rate drops significantly, for example, 16.9% for "gastric cancer".
The most important thing in cancer treatment is to detect cancer as early as possible.
The targets are solid cancers such as lung cancer, breast cancer, stomach cancer, liver cancer, colon cancer, tongue cancer, thyroid cancer, kidney cancer, prostate cancer, uterine cancer, and ovarian cancer.
*1 [Quote] (National Cancer Association Member InstitutionsJoint Survival Survey)
When cancer develops in the body, cancer-related substances are released into the blood. Cancer-related substances in the blood adsorbed to the test chip are measured using a fluorescence microscope, and the risk of cancer is determined in three stages, A, B, and C.
Only 30 microliters of blood is used for the test, and the test is not affected by food or other factors.
Another feature of this inspection is that the measured values appear with clear differences. In addition to early detection of cancer, it is a useful test for the risk of progression, recurrence/metastasis, and the risk of therapeutic effects.
Cancer-related substances: Protein complexes containing DNA (presumed nucleosomes) react with and are adsorbed by silver peroxide mesocrystals, a new substance formed on the ProteoⓇ chip. By looking at this with a fluorescence microscope, it is possible to detect even very early stage cancers, making it possible to identify and examine multiple cancers in a single examination.
It is very difficult to distinguish between benign and malignant tumors, and highly sensitive and highly specific testing methods are required.
Crystals of free cancer-related substances in the blood are substances derived from cells related to apoptosis, so the amount contained in benign diseases (people who do not have cancer) and benign tumors is small, and they are specific to cancer. It has many features.
More fluorescence is seen in malignant tumors than in benign diseases and benign tumors.
Inspection amount
Collection fee + inspection fee: 200,000 yen (tax included)
*This treatment is free medical treatment.
Inspection flow
1. Collect a small amount of blood from your fingertip.
2. Sent to a professional inspection agency for inspection. ProteoⓇ test results are digitized, risk assessment is performed, and a test result report is sent to the doctor.
3. Based on the test results report, the doctor will explain the results. Depending on the results, we will recommend additional tests and future treatments.
Q&A
Do I need to refrain from eating or drinking before blood collection?
Tests with ProteoⓇ are not affected by food or drink, so there is no need for dietary restrictions. However, please refrain from excessive alcohol intake.
Can I use health insurance?
Health insurance is not applicable because it is treated as a free medical treatment.
